Sun Pharmaceutical Industries Ltd. delivered on its quarterly profit in July-September 2025, helped by strong demand for its drugs in India. Operational profitability, however, dipped. Sun Pharma’s US sales dipped 4.1% year-on-year to ₹4,400 crore in July-September 2025. (Reuters) Net profit of India’s largest drugmaker rose 2.6% over the year-ago period to ₹3,118 crore in […]
